Avidity Biosciences Inc
RNAM
Rank in Stocks
#2082
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Share Price
$71.34
Last synced: 2026-03-03
Market Cap
$9.84B
Change (1 day)
0.00%
Change (1 year)
-
Country
US
Trade Avidity Biosciences Inc (RNAM)
Category
Healthcare
Stock split history for Avidity Biosciences Inc (RNAM)
Avidity Biosciences Inc stock (symbol: RNAM) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One RNAM share bought prior to Oct 22, 2026 would equal to 0 RNAM shares today.
The most recent stock split occurred on Oct 22, 2026.
One RNAM share bought prior to Oct 22, 2026 would equal to 0 RNAM shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
